Evaluation of vitamin-producing and immunomodulatory lactic acid bacteria as a potential co-adjuvant for cancer therapy in a mouse model.

R Levit Graciela Savoy de Giori Alejandra de Moreno de LeBlanc Jean Guy LeBlanc

Published in: Journal of applied microbiology (2020)

This bacterial mixture could prevent the interruption of conventional oncologic therapies by reducing undesirable side-effects. In addition, this blend would provide essential nutrients (vitamins) to oncology patients.

Keyphrases

lactic acid
cancer therapy
mouse model
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
early stage
peritoneal dialysis
palliative care
prognostic factors
prostate cancer
rectal cancer
radical prostatectomy
patient reported outcomes